Heart rhythm study probes why some patients tolerate VT better than others

NCT ID NCT05841199

Recruiting now Knowledge-focused Sponsor: Imperial College London Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study at Imperial College London will enroll 70 people undergoing heart catheterization to understand why some patients tolerate ventricular tachycardia (VT) better than others. Researchers will measure blood pressure and blood flow in the heart during simulated fast heart rates. The goal is to see how coronary artery disease and stents affect VT tolerability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better predict which patients are at risk from dangerous heart rhythms and guide treatment decisions.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test a new therapy, and results may not change current practice immediately.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder coronary microvascular disorder heart failure Microvascular Angina ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE CORONARY MICROVASCULAR DISEASE CORONARY MICROVASCULAR DYSFUNCTION HEART FAILURE VENTRICULAR TACHYCARDIA

Contacts and locations

Locations

Imperial College NHS Foundation Trust
RECRUITING

London, W12 0HS, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.